Cargando…

Diagnosis and management of intestinal Behçet’s disease

Behçet’s disease (BD) is a chronic relapsing disease with multiple organ system involvement characterized clinically by oral and genital aphthae, cutaneous lesions, and ophthalmological, neurological, and/or gastrointestinal manifestations. Little clinical evidence is available regarding the managem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hisamatsu, Tadakazu, Naganuma, Makoto, Matsuoka, Katsuyoshi, Kanai, Takanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2014
Materias:	Clinical Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037558/ https://www.ncbi.nlm.nih.gov/pubmed/24883128 http://dx.doi.org/10.1007/s12328-014-0488-0

Ejemplares similares

Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods
por: Kanai, Takanori, et al.
Publicado: (2014)

Treatment and outcomes: medical and surgical treatment for intestinal Behçet's disease
por: Hisamatsu, Tadakazu, et al.
Publicado: (2017)

β-(1,3)-Glucan derived from Candida albicans induces inflammatory cytokines from macrophages and lamina propria mononuclear cells derived from patients with Crohn's disease
por: Mori, Kiyoto, et al.
Publicado: (2018)

Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy
por: Takayama, Tetsuro, et al.
Publicado: (2015)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn’s disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2018)

Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021
por: Nakase, Hiroshi, et al.
Publicado: (2023)

TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease
por: Yoneno, Kazuaki, et al.
Publicado: (2013)

The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies
por: Hisamatsu, Tadakazu, et al.
Publicado: (2013)

Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2021)

Macrophages and Dendritic Cells Emerge in the Liver during Intestinal Inflammation and Predispose the Liver to Inflammation
por: Mikami, Yohei, et al.
Publicado: (2014)

The gut microbiota and inflammatory bowel disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2014)

Endoscopic and Pathologic Changes of the Upper Gastrointestinal Tract in Crohn's Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2014)

Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in active mesenteric panniculitis patients: A case report
por: Mizuno, Shinta, et al.
Publicado: (2017)

Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in Remission
por: Hisamatsu, Tadakazu, et al.
Publicado: (2015)

Current new challenges in the management of ulcerative colitis
por: Fukuda, Tomohiro, et al.
Publicado: (2019)

Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2022)

Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants
por: Watanabe, Kenji, et al.
Publicado: (2020)

Update on the diagnosis and management of Behçet’s disease
por: Rokutanda, Ryo, et al.
Publicado: (2014)

Efficacy of Calcineurin Inhibitors for Induction of Remission in Intestinal Behçet’s Disease
por: Kawaguchi, Takaaki, et al.
Publicado: (2022)

Recent trends in diagnostic techniques for inflammatory bowel disease
por: Naganuma, Makoto, et al.
Publicado: (2015)

Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease
por: Lee, Hyun Jung, et al.
Publicado: (2017)

Novel, Objective, Multivariate Biomarkers Composed of Plasma Amino Acid Profiles for the Diagnosis and Assessment of Inflammatory Bowel Disease
por: Hisamatsu, Tadakazu, et al.
Publicado: (2012)

First aid with color atlas for the use of intestinal ultrasound for inflammatory bowel disease in daily clinical practice
por: Miyoshi, Jun, et al.
Publicado: (2023)

Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: Registry and Social network)
por: Yamazaki, Hajime, et al.
Publicado: (2019)

Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients
por: Mizuno, Shinta, et al.
Publicado: (2017)

Update on the Diagnosis of Behçet’s Disease
por: Alibaz-Oner, Fatma, et al.
Publicado: (2022)

Outcome Predictors for Intestinal Behçet's Disease
por: Park, Jae Jun, et al.
Publicado: (2013)

The Diagnosis and Management of Vasculo-Behçet's Disease
por: Yoshimi, Ryusuke
Publicado: (2018)

Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations
por: Kalra, Seema, et al.
Publicado: (2013)

Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
por: Cheon, Jae Hee
Publicado: (2021)

Updated treatment strategies for intestinal Behçet’s disease
por: Park, Yong Eun, et al.
Publicado: (2018)

The treatment principles and targets for intestinal Behcet’s disease
por: He, Kun, et al.
Publicado: (2023)

Trends in Corticosteroid Prescriptions for Ulcerative Colitis and Factors Associated with Long-Term Corticosteroid Use: Analysis Using Japanese Claims Data from 2006 to 2016
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2020)

Challenges in the Timely Diagnosis of Behcet’s Disease
por: Hassan, Fadi, et al.
Publicado: (2023)

Adalimumab in the management of Behçet’s disease
por: Ueda, Atsuhisa, et al.
Publicado: (2015)

Intestinal Perforations in Behçet’s Disease
por: Chou, Shao-Jiun, et al.
Publicado: (2007)

Toll-Like Receptor 7 Agonist–Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells
por: Kiyohara, Hiroki, et al.
Publicado: (2018)

Behçet Disease
por: Di Dier, Kelly, et al.
Publicado: (2022)

Diagnosis/Classification Criteria for Behcet's Disease
por: Davatchi, Fereydoun
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gi0qsb609ii5ah6mqj66avqvlg